[3H]MK-801 binding and the mRNA for the NMDAR1 subunit of the NMDA receptor are differentially distributed in human and rat forebrain

Molecular Brain Research

Volumn 54, Issue 1, 1998, Pages 13-23

  Meoni, P ^a   Mugnaini, M ^b   Bunnemann, B H ^b   Trist, D G ^b   Bowery, N G ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Human brain; In situ hybridization; MK 801; NMDA receptor; Rat brain

Indexed keywords

DIZOCILPINE; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RADIOLIGAND; TRITIUM; DIZOCILPINE MALEATE; NMDA RECEPTOR A1;

AGED; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CAUDATE NUCLEUS; CLAUSTRUM; DRUG BINDING; FEMALE; FOREBRAIN; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LIGAND BINDING; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE; TISSUE DISTRIBUTION; ANIMAL; ANTIBODY SPECIFICITY; BINDING SITE; BRAIN CORTEX; COMPARATIVE STUDY; GENETICS; HISTOLOGY; METABOLISM;

AGED; AGED, 80 AND OVER; ANIMALS; AUTORADIOGRAPHY; BINDING SITES; CEREBRAL CORTEX; DIZOCILPINE MALEATE; FEMALE; HIPPOCAMPUS; HUMANS; IN SITU HYBRIDIZATION; MALE; ORGAN SPECIFICITY; PROSENCEPHALON; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER; TRITIUM;

EID: 0031886120     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00289-1     Document Type: Article

References (46)

1. Akbarian S., Sucher N.J., Bradley D., Tafazzoli A., Trinh D., Hetrick W.P., Potkin S.G., Sandman C.A., Bunney W.E. Jr., Jones E.J. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J. Neurosci. 16:1996;19-30.
2. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12:1989;366-375.
3. Audinat E., Knopfel T., Gawhiler B.H. Responses to excitatory acids of purkinje cells' and neurons of the deep nuclei in cerebellar slice cultures. J. Physiol. (Lond.). 430:1990;297-313.
4. Ball E.F., Shaw P.J., Ince P.G., Johnson M. The distribution of excitatory amino acid and basal ganglia with implications for Parkinson's disease: a quantitative autoradiographic study using [3H]MK801, [3H]glycine, [3H]CNQX and [3H]kainate. Brain Res. 658:1994;209-218.
5. Blandini F., Greenamyre J.T., Nappi G. The role of glutamate in the pathophysiology of Parkinson's disease. Funct. Neurol. 11:1996;3-15.
6. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 361:1993;31-39.
7. Bowery N.G., Wong E.H.F., Hudson A.L. Quantitative autoradiography of [3H]MK801 binding sites in mammalian brain. Br. J. Pharmacol. 93:1988;944-954.
8. B.G. Bunney, W.R. Bunney, Jr., A. Carlsson, Schizophrenia and glutamate, in: F.E. Bloom, D.J. Kupfer (Eds.), Psychopharmacology: The Fourth Generation of Progress, Raven, New York, 1995, pp. 1205-1214.
9. Cotman C.W., Flatman J.A., Ganong A.H., Perkins M.N. Effects of excitatory amino acid antagonists on evoked and spontaneous excitatory potentials in guinea-pig hippocampus. J. Physiol. (Lond.). 378:1986;403-415.
10. Del Bel E.A., Slater P. Binding to the glycine site of the NMDA receptor complex in brains of patients with Alzheimer's disease. Neurosci. Lett. 131:1991;75-78.
11. Ehlers M.D., Whittermore G.T., Huganir R.L. Regulated subcellular distribution of the NR1 subunit of the NMDA receptor. Science. 269:1995;1734-1737.
12. Garthwaite G., Yamini B., Garthwaite J. Selective loss of Purkinje and granule cell responsiveness to NMDA in rat cerebellum during development. Dev. Brain Res. 36:1987;288-292.
13. Ishimaru M., Kurumaji A., Toru M. Increases in strychnine-insensitive glycine binding sites in cerebral cortex of chronic schizophrenics: evidence for glutamate hypothesis. Biol. Psychiatry. 35:1994;84-95.
14. Hoffman P.L., Tabakoff B. Mechanisms and consequences of ethanol NMDA receptor interactions. J. Neurochem. 62:1994;S24.
15. Hollmann M., Boutter J., Maron C., Beasley L., Sullivan J., Pecht G., Neinemann S. Zinc potentiates agonist-induced currents at certain splice variants of the NMDA receptor. Neuron. 10:1993;943-954.
16. Hossmann K.A. Glutamate-mediated injury in focal cerebral ischemia: the excitotoxin hypothesis revised. Brain Pathol. 4(1):1994;23-26.
17. Huettner J.E. Glutamate receptor channels in rat DRG neurons: activation by kainate and quisqualate and blockade of desensitization by concanavalin A. Neuron. 5:1990;255-286.
18. Katsuki H., Kaneko S., Tajima A., Satoh M. Separate mechanisms of long term potentiation in 2 input systems to CA3 pyramidal neurons of rat hippocampal slices as revealed by the whole-cell patch clamp technique. Neurosci. Res. 12:1991;393-402.
19. Lahtinen H., Castren E., Miettinen R., Ylinen A., Paljarvi K., Riekkinen P.J. Sr. NMDA-sensitive [3H]glutamate binding in the epileptic rat hippocampus: an autoradiographic study. Neuroreport. 4:1993;45-48.
20. McBain C.J., Mayer M.L. N-Methyl-D-aspartatic acid receptor structure and function. Physiol. Rev. 74-3:1994;723-760.
21. McDonald J.W., Garofalo E.A., Hood T., Sackellares J.C., Gilman S., McKeever P.E., Troncoso J.C., Johnston M.V. Altered excitatory and inhibitory amino acid receptor binding in hippocampus of patients with temporal lobe epilepsy. Ann. Neurol. 29-5:1991;529-541.
22. Monaghan D.T. Differential stimulation of [3H]MK801 binding to subpopulations of NMDA receptors. Neurosci. Lett. 122:1991;21-24.
23. Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H., Burnashev N., Sakmann B., Seeburg P.H. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science. 256:1992;1217-1221.
24. Moriyoshi K., Masu M., Ishii T., Shigemoto R., Mizuno N., Nakanishi S. Molecular cloning and characterization of the rat NMDA receptor. Nature. 354:1991;31-37.
25. Peltz S.W., Brewer G., Bernstein P., Hart P.A., Ross J. Regulation of mRNA turnover in eukaryotic cells. Crit. Rev. Euc. Gene Expr. 1:1991;99-126.
26. Petralia R.S., Yokotani N., Wenthold H. Light and electron microscope distribution of the NMDA receptor subunit NMDAR1 in the rat nervous system using a selective anti-peptide antibody. J. Neurosci. 14:1994;667-696.
27. Planells-Cases R., Sun W., Ferrer-Montiel A., Montal M. Molecular cloning, functional expression, and pharmacological characterization of an N-methyl-D-aspartate receptor subunit from the human brain. Proc. Natl. Acad. Sci. USA. 90:1993;5057-5061.
28. Porter R.H., Greenamyre J.T. Regional variations in the pharmacology of NMDA receptor channel blockers: implication for therapeutic potential. J. Neurochem. 64:1995;614-623.
29. Reynolds I.J., Palmer A.M. Regional variations in [3H]MK801 binding to rat brain NMDA receptors. J. Neurochem. 56:1991;1731-1740.
30. Rosenmund C., Legendre P., Westbrook G.L. Expression of NMDA channels in cerebellar purkinje cells acutely dissociated from newborn rats. J. Neurophysiol. 68:1992;1901-1905.
31. Sachs A.B. Messenger RNA degradation in eukaryotes. Cell. 74:1993;413-421.
32. Sakurai S.Y., Cha H.J., Penney J.B., Young A.B. Regional distribution and properties of [3H]MK801 binding sites determined by quantitative autoradiography in rat brain. Neuroscience. 40:1991;533-543.
33. Siegel S.J., Brose N., Janssen W.G., Gasic G.P., Jahn R., Heinemann S.F. Regional, cellular, and ultrastructural distribution of NMDA receptor subunit 1 in monkey hippocampus. Proc. Natl. Acad. Sci. USA. 91:1994;564-568.
34. Shigemoto R., Ohishi H., Nakanishi S., Mizuno N. Expression of the mRNA for the rat NMDA receptor (NMDAR1) in the sensory and autonomic ganglion neurons. Neurosci. Lett. 144:1992;229-232.
35. Stephan H., Andy O.J. Quantitative comparative neuroanatomy of primates: an attempt at a phylogenetic interpretation. Ann. New York Acad. Sci. 167:1969;370-387.
36. Sucher N.J., Brose N., Deitcher D.L., Awobuluyi M., Gasic G.P., Bading H., Cepko C., Greenberg M.E., Jahn R., Heinemann S.F., Lipton S.A. Expression of endogenous NMDAR1 transcripts without receptor protein suggests post-transcriptional control in PC12 cells. J. Biol. Chem. 268:1993;22299-22304.
37. Tolle T.R., Berthele A., Laurie D.J., Seeburg P.H., Zieglgansberger W. Cellular and subcellular distribution of NMDAR1 splice variant mRNA in the rat lumbar spinal cord. Eur. J. Neurosci. 7:1995;1235-1244.
38. Ulas J., Brunner L.C., Geddes J.W., Choe W., Cotman C.W. N-Methyl-D-aspartate receptor complex in the hippocampus of elderly, normal individuals and those with Alzheimer's disease. Neuroscience. 49:1992;45-61.
39. Ulas J., Weihmuller F.B., Brunner L.C., Joyce J.N., Marshall J.F., Cotman C.W. Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, and mixed Parkinson's disease/Alzheimer's disease patients: an autoradiographic study. J. Neurosci. 14:1994;6317-6324.
40. K.L. Valentino, J.H. Eberwine, J.D. Barchas, In Situ Hybridization - Application to Neurobiology, Oxford University Press, New York, 1994.
41. Watkins J.C., Evans R.H. Excitatory amino acid transmitters. Annu. Rev. Pharmacol. Toxicol. 21:1981;165-204.
42. Woodward R.M., Huettner J.E., Tron M., Guastella J., Keana J.F., Weber H. Pharmacology of 5-chloro-7-trifluoromethyl-1,4-dihydro-2,3-quinoxalinedione: a novel systematically active ionotropic glutamate receptor antagonist. J. Pharmacol. Exp. Ther. 275:1995;1209-1218.
43. Young A.B., Fagg G.E. Excitatory amino acid receptors in the brain: membrane binding and receptor autoradiographic approaches. Trends Pharmacol. Sci. 11:1990;126-133.
44. Zimmer M., Fink T.M., Franke Y., Lichter P., Spiess J. Cloning and structure of the gene encoding the human N-Methyl-D-aspartate receptor (NMDAR1). Gene. 159:1995;219-223.
45. Zukin R.S., Bennett M.V.L. Alternatively spliced isoforms of the NMDAR1 receptor subunit. Trends Neurol. Sci. 18:1995;306-313.
46. Rigby M., Le Bourdelles B., Heavens R.P., Kelly S., Smith D., Butler A., Hammans R., Hills R., Xuereb J.H., Hill R.G., Whiting P.J., Sirinathsinghji The messenger RNAs for the N-methyl-D-aspartate receptor subunits show region-specific expression of different subunit composition in the human brain. Neuroscience. 73:1996;429-447.